Ask a Patient® Health News: Drugs & Treatments

July 2025 Safety Update: New drug for hand eczema, heart failure; warnings for testosterone meds, Opdivo; FDA halts Elevidys gene therapy; green tea drug interactions; anemia in older patients

Special Update on Alzheimer’s Drugs Leqembi (lecanemab) and Kisunla (donanemab)

Expanded Approvals for Dupixent, Keytruda, Mavyret, Nucala, Susvimo; New Meds: Widaplik for High Blood Pressure, Yeztugo for HIV prevention

June 2025 Safety Update Part 2: Warnings for Transderm Scop, Caprelsa, Hyzaar, Xarelto, GLP-1s (Mounjaro and more)

June 2025 Drug Safety Update: Recalls of Carvedilol, Zicam Nasal Swabs, Generic Bactrim; New Warnings for Depakote and Lamictal; GLP-1 meds and Eye Disease (wet AMD)

Nationwide eye drops recall; New lung, liver, ovarian cancer drugs; Gene therapy trial tragedy; new migraine injectable; Allergy med tips; Fish oil supplement good news; more

May 2025 Safety Update Part 2: Spravato Antidepressant, Clozapine, Ambrisentan, Korean Sunscreens, Children's Claritin, "Gas Station Heroin," Fluoride Tablets, Medication Tips

May 2025 Safety Update: Duloxetine Recall; New Warnings for Gabapentin, Lyrica, Doxycycline, Other Antibiotics; Animal Testing Changes; FDA Delays Continue; Medication Tips

Phase-out of Animal Studies Requirement for Investigational New Drug Applications

FDA Delays Some Updates; Product Warnings for Topical Hair Loss Treatment; Supplements with Hidden Ingredients; Counterfeit Ozempic

April 2025 Drug Safety: Lidocaine cream; new side effects for migraine drugs; antidepressants study; Pluvicto for prostate cancer; Imfinzi; Tymlos; vitamin B-12 quality; microplastics in teabags

March 2025 Drug Safety Part 2: New warnings for MRI contrast agents; Baqsimi, Belsomra, Furoscix, Iluvien ophthalmic, Metronidazole; Recalls of ADHD and acne meds; medication tips